Detalles de la búsqueda
1.
The patient's perspective on treatment with dacomitinib: patient-reported outcomes from the Phase III trial ARCHER 1050.
Future Oncol;
17(7): 783-794, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33164569
2.
Relationship between molecular response and quality of life with bosutinib or imatinib for chronic myeloid leukemia.
Ann Hematol;
99(6): 1241-1249, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32307568
3.
Long-term patient-reported outcomes from an open-label safety and efficacy study of bosutinib in Philadelphia chromosome-positive chronic myeloid leukemia patients resistant or intolerant to prior therapy.
Cancer;
124(3): 587-595, 2018 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29072772
4.
First-line crizotinib versus chemotherapy in ALK-positive lung cancer.
N Engl J Med;
371(23): 2167-77, 2014 Dec 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-25470694
5.
Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study.
Clin Infect Dis;
54(5): 621-9, 2012 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22247123
6.
Comparison of serotonin toxicity with concomitant use of either linezolid or comparators and serotonergic agents: an analysis of Phase III and IV randomized clinical trial data.
J Antimicrob Chemother;
67(2): 494-502, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-22139199
7.
Patient-reported outcomes from the randomized phase 3 CROWN study of first-line lorlatinib versus crizotinib in advanced ALK-positive non-small cell lung cancer.
Lung Cancer;
174: 146-156, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36410210
8.
Anidulafungin compared with fluconazole for treatment of candidemia and other forms of invasive candidiasis caused by Candida albicans: a multivariate analysis of factors associated with improved outcome.
BMC Infect Dis;
11: 261, 2011 Sep 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-21961941
9.
Anidulafungin compared with fluconazole in severely ill patients with candidemia and other forms of invasive candidiasis: support for the 2009 IDSA treatment guidelines for candidiasis.
Crit Care;
15(5): R253, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-22026929
10.
Impact of lorlatinib on patient-reported outcomes in patients with advanced ALK-positive or ROS1-positive non-small cell lung cancer.
Lung Cancer;
144: 10-19, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32344248
11.
Patient-reported outcomes in the phase 3 BFORE trial of bosutinib versus imatinib for newly diagnosed chronic phase chronic myeloid leukemia.
J Cancer Res Clin Oncol;
145(6): 1589-1599, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-30989330
12.
Onset of symptom resolution in adults with acute bacterial rhinosinusitis treated with a single dose of azithromycin extended release compared with 10 days of levofloxacin: a retrospective analysis of a randomized, double-blind, double-dummy trial.
Clin Ther;
29(12): 2690-8, 2007 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-18201585
13.
Final results of the large-scale multinational trial PROFILE 1005: efficacy and safety of crizotinib in previously treated patients with advanced/metastatic ALK-positive non-small-cell lung cancer.
ESMO Open;
2(3): e000219, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-29209525
14.
Health-related quality of life during bosutinib (SKI-606) therapy in patients with advanced chronic myeloid leukemia after imatinib failure.
Curr Med Res Opin;
32(8): 1325-34, 2016 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27045164
15.
Evaluation of Tigecycline Efficacy and Post-Discharge Outcomes in a Clinical Practice Population with Complicated Intra-Abdominal Infection: A Propensity Score-Matched Analysis.
Surg Infect (Larchmt);
17(4): 402-11, 2016 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-26981640
16.
Value of Propensity Score Matching for Equalizing Comparator Groups in Observational Database Studies: A Case Study in Anti-infectives.
Clin Ther;
38(12): 2676-2681, 2016 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-27866659
17.
Patient-Reported Outcomes and Quality of Life with Sunitinib Versus Placebo for Pancreatic Neuroendocrine Tumors: Results From an International Phase III Trial.
Target Oncol;
11(6): 815-824, 2016 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27924459
18.
Clinical outcomes by methicillin-resistant Staphylococcus aureus staphylococcal cassette chromosome mec type: isolates recovered from a phase IV clinical trial of linezolid and vancomycin for complicated skin and skin structure infections.
Antimicrob Agents Chemother;
54(9): 4036-7, 2010 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-20585131
19.
The safety of azithromycin in the treatment of adults with community-acquired respiratory tract infections.
Int J Antimicrob Agents;
19(3): 189-94, 2002 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-11932140
20.
Patient-reported outcomes and quality of life in PROFILE 1007: a randomized trial of crizotinib compared with chemotherapy in previously treated patients with ALK-positive advanced non-small-cell lung cancer.
J Thorac Oncol;
9(11): 1625-33, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25436797